Esquire Financial Holdings, Inc. — Q1 2024 Form 10-Q
Business context and period. This unaudited quarterly report covers the three months ended March 31, 2024, compared primarily with the three months ended March 31, 2023. Esquire is a branchless commercial bank focused on legal-industry banking and payment processing, alongside regional commercial and consumer banking. Amounts below are in U.S. dollars; financial statement amounts are in millions unless noted.
Key financial results
| Metric | Q1 2024 | Q1 2023 / prior date |
|---|---|---|
| Interest income | $26.1 | $20.4 |
| Net interest income | $22.9 | $19.3 |
| Provision for credit losses | $1.0 | $0.5 |
| Noninterest income | $6.4 | $10.3 |
| Noninterest expense | $14.6 | $12.5 |
| Net income | $10.1 | $12.2 |
| Basic / diluted EPS | $1.29 / $1.20 | $1.58 / $1.47 |
| Net interest margin | 6.06% | 6.03% |
- Management reported return on average assets of 2.59%, return on average equity of 20.14%, and an efficiency ratio of 49.8% for Q1 2024.
- At March 31, total assets were $1.654 billion, up 2.3% from year-end 2023. Loans held for investment were $1.228 billion before allowance, up $20.6 million; deposits were $1.434 billion, up $26.8 million.
- Cash and cash equivalents were $158.2 million, down $7.0 million from year-end. Q1 operating cash flow was $12.8 million, investing cash outflow was $45.2 million, and financing cash inflow was $25.4 million.
- Stockholders’ equity was $207.1 million. The bank reported no outstanding FHLB or Federal Reserve borrowings; available liquidity, including cash, borrowing capacity and eligible reciprocal sweep balances, was $822.6 million, or 57% of deposits.
- Allowance for credit losses was $17.5 million, or 1.43% of loans, versus $16.6 million, or 1.38%, at year-end. Nonperforming assets consisted of one $10.9 million multifamily loan. The allowance equaled 160% of nonperforming loans.
Material changes versus the prior comparable period
- Net income fell 17.4%, primarily because Q1 2023 included a nonrecurring $4.0 million gain on an equity investment. Excluding that comparison effect, net interest income growth was a key positive.
- Net interest income rose 18.5%, as interest income grew $5.7 million, partly offset by a $2.1 million increase in interest expense. Average loan balances and yields increased; deposit costs also rose as interest rates and relationship-deposit pricing increased.
- Noninterest income declined 37.7% to $6.4 million. Payment processing fees decreased 3.9% to $5.3 million, while administrative service income rose 41.0% to $746,000. The prior-year equity investment gain did not recur.
- Noninterest expense increased 16.7%, with higher compensation, data processing, marketing, travel and regulatory assessments. Staffing rose 18% year over year to 139 full-time equivalents.
- Payment processing volume grew 12.2% to $8.6 billion; processed transactions increased 5.3% to 150.5 million. Litigation-related loans grew to $636.6 million, 51.8% of the loan portfolio.
- Available-for-sale securities increased to $142.2 million, while their unrealized loss widened to $19.8 million before tax; the quarter recorded a $1.1 million after-tax other comprehensive loss.
Outlook, commentary and principal risks
- The filing provides no specific numerical earnings or growth guidance. Management describes continued investment in people, technology and digital marketing to support long-term growth.
- Management characterizes the balance sheet as asset-sensitive: approximately 60% of loans are variable-rate and tied to prime, with floors on 90% of variable-rate loans. Its modeled 12-month net interest income changes from a baseline of $103.4 million by +$15.7 million under a 300-basis-point increase and by -$14.8 million under a 300-basis-point decrease. These are model estimates, not forecasts, and depend on assumptions and management actions.
- Funding is concentrated in relationships tied to litigation and payment processing: these represented approximately 87% of deposits. Uninsured deposits were $369.4 million, or 26% of deposits, excluding affiliate deposits; management said about 80% of uninsured deposits were from clients with broader banking relationships. Off-balance-sheet sweep funds were $466.6 million.
- Key disclosed risks include credit deterioration, particularly in real estate and litigation-related lending; interest-rate movements and deposit pricing; potential uninsured-deposit outflows that could require securities sales at a loss; payment-processing and third-party operational risks; competition; and technology, cybersecurity, regulatory and economic uncertainty.
- Available-for-sale securities’ unrealized losses were attributed by management to interest rates rather than credit quality; the company said it did not intend, and was not likely to be required, to sell before recovery. No allowance for credit losses was recorded on those securities or on agency held-to-maturity securities.
- Management reported no pending legal proceeding expected to have a material adverse effect and no material change to the risk factors in its 2023 Form 10-K. Disclosure controls were assessed as effective; no material internal-control changes were reported during the quarter.
Important facts for investors to verify
- Whether loan growth and higher net interest income can offset rising deposit costs and expense growth, especially if rates change.
- Credit performance of the $10.9 million nonaccrual multifamily loan, the $4.0 million special-mention commercial exposure, and the broader CRE and litigation-related portfolios; also monitor allowance assumptions and charge-offs.
- Stability and concentration of litigation-related, payment-processing and uninsured deposits, including availability of off-balance-sheet sweep funds under stress.
- Potential consequences of prolonged low fair values in the securities portfolio, including the unrealized losses and any liquidity needs that could prompt sales.
- Reported diluted EPS of $1.20 versus basic EPS of $1.29; investors may wish to review the filing’s EPS calculation and share-based award dilution.